Binx Health is a health technology company that develops new approaches designed to diagnose and treat sexually transmitted infections (STIs). Their proprietary product is the Binx io point-of-care molecular platform, which aims to allow for rapid testing of chlamydia and gonorrhea. The platform can be used in various healthcare settings including doctor offices, urgent care facilities, and hospital emergency rooms, and strives to allow healthcare practitioners to deliver test results within 30 minutes with the goal of significantly reducing the amount of time between testing and diagnosis through traditional lab testing methods. Binx Health was founded in 2005 and is headquartered in Cambridge, MA.
Binx Health is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Binx Health pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Binx Health is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.